Comparison between Jio Platforms IPO and Ujin Pharma IPO.
Jio Platforms IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Ujin Pharma IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Jio Platforms IPO is up to ₹0.00 Cr whereas the issue size of the Ujin Pharma IPO is up to ₹0.00 Cr. The final issue price of Jio Platforms IPO is and of Ujin Pharma IPO is .
| Jio Platforms IPO | Ujin Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 27,00,00,000 shares | 1,18,69,100 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 72,82,300 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 27,00,00,000 shares | 1,91,51,400 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Jio Platforms IPO opens on , while Ujin Pharma IPO opens on . The closing date of Jio Platforms IPO and Ujin Pharma IPO is , and , respectively.
Jio Platforms IPO P/E ratio is , as compared to Ujin Pharma IPO P/E ratio of .
| Jio Platforms IPO | Ujin Pharma IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Jio Platforms Ltd.'s revenue increased by 16% and profit after tax (PAT) rose by 15% between the financial year ending with March 31, 2026 and March 31, 2025.
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 66.43 | 98.50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 12.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 10.76 | 12.54 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.57 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹33.62 | ₹2.60 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 9.42 | 11.87 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Jio Platforms IPO Retail Individual Investors (RII) are offered 0 shares while in Ujin Pharma IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Jio Platforms IPO and 0 shares in Ujin Pharma IPO.
| Jio Platforms IPO | Ujin Pharma IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Jio Platforms IPO subscribed in total, whereas Ujin Pharma IPO subscribed .
